Evaluation of relationship between pharmacokinetics and clinical response of voriconazole.
Not Applicable
Recruiting
- Conditions
- immunocompromised or fungal infection
- Registration Number
- JPRN-UMIN000023974
- Lead Sponsor
- Department of Hospital Pharmacy, Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
patients (1) on dialysis; (2) who had hepatopathy (total bilirubin > 2.0 mg/dL); (3) co-treated with rifampicin, ritonavir, carbamazepine, and long-acting barbiturates; and (4) with poor compliance with respect to their medications.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method